mimifa NMN+ 400 Capsules — 60 Count
$51.99
mimifa NMN+ 400 delivers 400 mg of NMN (nicotinamide mononucleotide) in every capsule — one of the highest single-capsule doses licensed for sale in Canada. NMN is a direct precursor to NAD+, a coenzyme found in every cell that plays a central role in energy metabolism. NAD+ levels naturally decline with age, and NMN supplementation is one of the most studied ways to support them.
Unlike unlicensed NMN products sold through grey-market channels, mimifa NMN+ 400 is fully licensed by Health Canada (NPN 80127839) — meaning its safety, quality, and label claims have been reviewed and approved. With the U.S. FDA having excluded NMN from the dietary supplement pathway, Canada is one of the few markets where consumers can buy licensed, regulated NMN — and mimifa offers it at a leading dose.
Each capsule pairs NMN with a natural botanical matrix of astragalus root extract and avocado powder. Made for health-conscious adults who want a serious, transparent longevity product from a Canadian brand.
Key Bullet Points
- 400 mg NMN per capsule — among the highest NMN doses available in Canada
- Health Canada Licensed (NPN 80127839) — reviewed and approved for sale; not a grey-market import
- NAD+ precursor — helps support energy metabolism and tissue formation
- Natural botanical matrix — astragalus root extract + avocado powder base
- Canadian brand, bilingual EN/FR label — 60 capsules per bottle; 1–2 month supply
Product Facts
| Brand | mimifa (Norvia Supply Corp, Vancouver, BC) |
| Format | Capsules — 60 per bottle |
| NPN | 80127839 (Health Canada Licensed) |
| Key ingredient | NMN (nicotinamide mononucleotide) 400 mg per capsule |
| Supporting ingredients | Astragalus root extract, avocado powder |
Reviews
There are no reviews yet.